InspireMD (NSPR) EBIT Margin Growth (5y) (2015 - 2025)
InspireMD (NSPR) EBIT Margin Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | InspireMD | 56.85 Mn | 2.64 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 196,942.00 |
| Sep 30, 2025 | -29,330.00 |
| Jun 30, 2025 | 4,924.00 |
| Mar 31, 2025 | -55,405.00 |
| Dec 31, 2024 | -23,322.00 |
| Sep 30, 2024 | -25,484.00 |
| Jun 30, 2024 | -31,376.00 |
| Mar 31, 2024 | 26,355.00 |
| Dec 31, 2023 | -6,144.00 |
| Sep 30, 2023 | -10,506.00 |
| Jun 30, 2023 | -17,546.00 |
| Mar 31, 2023 | -15,965.00 |
| Dec 31, 2022 | -30,735.00 |
| Sep 30, 2022 | -3,176.00 |
| Jun 30, 2022 | 5,269.00 |
| Mar 31, 2022 | 4,329.00 |
| Dec 31, 2021 | 36,546.00 |
| Sep 30, 2021 | -154.00 |
| Jun 30, 2021 | -437.00 |
| Mar 31, 2021 | 3,114.00 |